News

The tax claim principally relates to the allocation of taxes on profits for Glaxo Wellcome products between the US and other countries. GSK estimates that the interest owing

In the study, post-surgical use of Femara (letrozole tablets) in postmenopausal women with hormone receptor-positive early breast cancer demonstrated a significant 19% reduction in risk of relapse, reducing

No current vaccine is available to prevent hookworm disease, which is one of the most common chronic infections of humans with an estimated 740 million cases in areas

The successful application for fast track status was based on data derived from a phase Ib/IIa study, conducted in two Australian hospitals, in which men with late stage

The investigational PYY3-36 nasal spray is designed to deliver the natural, appetite-regulating hormone PYY directly to the bloodstream. Nastech has completed three phase I clinical trials, each designed

Procyon said that, in order to maximize shareholder value in the short to medium term, it would now shift its focus from being an early-stage research company to

The pivotal phase III trial is a double blind, placebo controlled, multicenter study. Patients with high grade prostatic intraepithelial neoplasia (PIN), the precancerous lesion in prostate cancer, will

ImClone’s financial results were affected by a $75 million payment to settle a 2002 consolidated class-action shareholder lawsuit, which had accused the company of making false or misleading

This multi-center, multi-national study is designed to assess the effectiveness of Mylinax in patients with relapsing forms of multiple sclerosis. Endpoints will include assessments of clinical relapses, disability